Install
Biotech
Biotechnology, gene editing, biopharma platforms, and clinical pipelines.
- 9 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
- Aerospace
- Agriculture
- Banking (Industry)
- Computing
- Consumer Goods
- Defense
- Energy & Utilities
- Entertainment
- Food & Beverage
- Government
- Healthcare
- Real Estate (Commercial)
- Management & Consulting
- Manufacturing
- Technology
- Telecom
- Transportation & Logistics
- Automotive
- Construction
- Education & EdTech
- Hospitality & Travel
- Insurance (Industry)
- Mining & Materials
- Pharmaceuticals
Latest in Biotech
FDA Approves Ultragenyx Fayuvi for Sanfilippo Syndrome - Pharmaceutical Industry News - Zenopa US
12+ hour, 36+ min ago (166+ words) Looks like you’re on the US site. Choose another location to see content specific to your location Use our advanced search tool to help find your next job in the US, EU or UK. Send us your CV and requirements…...
NVS Gets Positive CHMP Opinion for Cosentyx for Another Indication
3+ hour, 32+ min ago (579+ words) Novartis NVS announced that the Committee for Medicinal Products for Human Use ("CHMP") of the European Medicines Agency ("EMA") has issued a positive opinion recommending marketing authorization for an additional indication of its arthritis drug Cosentyx (secukinumab). The CHMP recommended…...
Addressing Residual Reagents and Impurities in Drug Development, Upcoming Webinar Hosted by Xtalks
6+ hour, 59+ min ago (107+ words) Register for this webinar to learn how impurities can be identified, assessed and controlled through risk-based analytical strategies across drug development. Join Alaknanda Mishra, PhD, Director of Advanced Therapeutics, BA Sciences; and Ramakrishna Battula, MSc, Senior Scientist, BA Sciences, for…...
Drug developer ADARx seeks $1.74 billion valuation in US IPO
2+ hour, 16+ min ago (327+ words) The offices of ADARx Pharmaceuticals in San Diego, California, U.S., August 3, 2026. REUTERS/Mike Blake Sept 21 (Reuters) - ADARx Pharmaceuticals, which develops RNA-based drugs for rare diseases, said on Monday that it was targeting a valuation of up to $1.74 billion, as it joins…...
Hanx Bio licenses XtalPi AI drug discovery platform for biologics R&D
3+ hour, 44+ min ago (363+ words) AllSci Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKEX: 03378) and XtalPi Holdings Limited (HKEX: 02228) have entered into a Strategic Cooperation Framework Agreement and a platform use license agreement granting Hanx access to XtalPi's AI-driven drug discovery platform, XtalPi Science, to support its…...
Lilly Breaks Ground as Houston’s Biopharma Sector Gains Momentum | Houston.org
1+ hour, 24+ min ago (735+ words) Houston is a thriving international metro boasting a diverse economy & population, and is the best place to live, work & grow your business. The Partnership is here to help with site selection, data, resources & more. Partner with us to locate & grow…...
Biotechnology Hearing Surfaces Oversight Gaps, Tradeoffs
1+ hour, 39+ min ago (328+ words) Rep. Emilia Strong Sykes (D-OH-13) highlighted the economic stakes. Recent estimates put the U.S. biotechnology sector's employment at more than 600,000 jobs and its annual contribution to national GDP at more than $200 billion. An Ohio life sciences survey found that the industry…...
Western licensing deals for Chinese radioligand therapies to jump in 2027, Sleuth forecasts
1+ hour, 16+ min ago (256+ words) Next year will bring a significant rise in deals between Chinese radioligand therapy developers and companies capable of supplying the drugs in the West, according to biopharma intelligence platform Sleuth. Sleuth predicts 2027 will be the year that Western in-licensing of…...
Recon: FDA staff raise no major concerns for Grail multi-cancer test ahead of adcomm; Trump admin drafting order to exert control over NIH grant funding
1+ hour, 49+ min ago (94+ words) The complete guide to formulating an effective global regulatory strategy for medical devices, created and curated by experts. Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, biopharma and medtech news stories…...
ADARx, Trex, and Retension take aim at IPOs
3+ hour, 16+ min ago (429+ words) The appetite among US biotechs for IPOs shows no signs of being satisfied, with three more companies – ADARx Pharma, TRex Bio, and Retension Pharma – joining the lunch queue. ADARx Pharmaceuticals, a San Diego-based biotech developing siRNA therapies for various diseases,…...